Related Experiment Video
Updated: Jul 16, 2025

05:45
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
9.7K
Interactions between microglia and glioma in tumor microenvironment
Jin-Cheng Tao1, Dong Yu2, Wei Shao2
1Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Frontiers in Oncology
|September 13, 2023
Summary
This review examines the role of microglia and other tumor-associated macrophages in glioma progression. It highlights challenges in distinguishing these cells and discusses current immunotherapies targeting microglia.
Area of Science:
- Neuro-oncology
- Immunology
- Cell Biology
Background:
- Gliomas are primary central nervous system tumors with poor prognosis due to immunosuppressive properties.
- The tumor microenvironment, particularly tumor-associated macrophages (TAMs), significantly influences glioma growth and invasion.
- Differentiating between brain-resident microglia and bone marrow-derived macrophages within TAMs is challenging.
Purpose of the Study:
- To analyze the heterogeneity between microglia and other brain-resident macrophages.
- To elucidate the complex interactions between microglia and glioma cells.
- To summarize current immunotherapies targeting microglia for glioma treatment.
Main Methods:
- Literature review and analysis of existing research on microglia and glioma.
- Comparative analysis of microglia and bone marrow-derived macrophages.
- Synthesis of findings on microglia-glioma cell interactions and immunotherapy strategies.
Main Results:
- Microglia play a critical role in creating a pro-tumorigenic microenvironment in gliomas.
- Significant heterogeneity exists between microglia and other TAMs, impacting their function.
- Current immunotherapies targeting microglia show potential but face limitations.
Conclusions:
- Understanding microglia heterogeneity and interactions is crucial for effective glioma treatment.
- Targeting microglia represents a promising avenue for glioma immunotherapy.
- Further research is needed to overcome current limitations and advance microglia-based therapies.

